Pfizer vs UBS Group AG
Comparaison de la capitalisation boursière au fil du temps
Pfizer
$153.2B
Rang #115
UBS Group AG
$159.9B
Rang #110
Capitalisation boursière au fil du temps
Moments clés
- Pfizer a dépassé UBS Group AG avant 1998
- UBS Group AG a dépassé Pfizer avant 1999
- Pfizer a dépassé UBS Group AG avant 2008
- UBS Group AG a dépassé Pfizer avant 2026
Comparaison année par année
| Année | Pfizer | UBS Group AG | Leader |
|---|---|---|---|
| 2026 | $153.2B | $159.9B | UBS Group AG |
| 2025 | $137.3B | $131.3B | Pfizer |
| 2024 | $136.4B | $94.7B | Pfizer |
| 2023 | $139.5B | $86.7B | Pfizer |
| 2022 | $237.5B | $55.5B | Pfizer |
| 2021 | $265.1B | $51.4B | Pfizer |
| 2020 | $159.1B | $38.1B | Pfizer |
| 2019 | $154.3B | $35.0B | Pfizer |
| 2018 | $165.8B | $33.2B | Pfizer |
| 2017 | $132.8B | $46.8B | Pfizer |
| 2016 | $114.6B | $41.6B | Pfizer |
| 2015 | $109.7B | $48.1B | Pfizer |
| 2014 | $102.5B | $40.5B | Pfizer |
| 2013 | $97.3B | $39.6B | Pfizer |
| 2012 | $77.1B | $32.4B | Pfizer |
| 2011 | $64.0B | $25.2B | Pfizer |
| 2010 | $49.7B | $34.5B | Pfizer |
| 2009 | $49.6B | $36.7B | Pfizer |
| 2008 | $45.8B | $33.4B | Pfizer |
| 2007 | $55.2B | $117.9B | UBS Group AG |
| 2006 | $60.1B | $161.9B | UBS Group AG |
| 2005 | $52.1B | $136.7B | UBS Group AG |
| 2004 | $58.3B | $104.2B | UBS Group AG |
| 2003 | $75.0B | $92.6B | UBS Group AG |
| 2002 | $63.7B | $73.5B | UBS Group AG |
| 2001 | $81.9B | $91.6B | UBS Group AG |
| 2000 | $93.5B | $95.7B | UBS Group AG |
| 1999 | $65.4B | $77.8B | UBS Group AG |
| 1998 | $83.3B | $76.4B | Pfizer |
| 1997 | $49.3B | $76.2B | UBS Group AG |
| 1996 | $27.1B | $42.6B | UBS Group AG |
| 1995 | $20.2B | $47.6B | UBS Group AG |